[HTML][HTML] Recommendations for enterovirus diagnostics and characterisation within and beyond Europe

…, M Cabrerizo, M Majumdar, G Nebbia… - Journal of clinical …, 2018 - Elsevier
Enteroviruses (EV) can cause severe neurological and respiratory infections, and occasionally
lead to devastating outbreaks as previously demonstrated with EV-A71 and EV-D68 in …

[HTML][HTML] Clinical features and management of human monkeypox: a retrospective observational study in the UK

…, A Luintel, E MacMahon, G Nebbia… - The Lancet Infectious …, 2022 - thelancet.com
Background Cases of human monkeypox are rarely seen outside of west and central Africa.
There are few data regarding viral kinetics or the duration of viral shedding and no licensed …

[HTML][HTML] Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans

…, G O'Hara, E MacMahon, S Douthwaite, G Nebbia… - Nature …, 2020 - nature.com
Antibody responses to SARS-CoV-2 can be detected in most infected individuals 10–15 d
after the onset of COVID-19 symptoms. However, due to the recent emergence of SARS-CoV-…

[HTML][HTML] Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort …

…, A Patel, T Charalampous, G Nebbia… - The Lancet Infectious …, 2022 - thelancet.com
Background The SARS-CoV-2 delta (B.1.617.2) variant was first detected in England in March,
2021. It has since rapidly become the predominant lineage, owing to high transmissibility. …

Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak: descriptive case series

…, M Abeywickrema, C Pley, V Naidu, G Nebbia… - bmj, 2022 - bmj.com
Objective To characterise the clinical features of monkeypox infection in humans. Design
Descriptive case series. Setting A regional high consequences infectious disease centre with …

[PDF][PDF] Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity

…, C Bresner, LB Snell, T Charalampous, G Nebbia… - Cell, 2021 - cell.com
Global dispersal and increasing frequency of the SARS-CoV-2 spike protein variant D614G
are suggestive of a selective advantage but may also be due to a random founder effect. We …

[HTML][HTML] Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study

…, A Patel, T Charalampous, G Nebbia… - The Lancet Public …, 2021 - thelancet.com
Background The SARS-CoV-2 variant B.1.1.7 was first identified in December, 2020, in
England. We aimed to investigate whether increases in the proportion of infections with this …

Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell–mediated deletion

…, LJ Pallett, A Schurich, L Micco, G Nebbia… - Journal of Experimental …, 2013 - rupress.org
Antiviral T cell responses in hepatotropic viral infections such as hepatitis B virus (HBV) are
profoundly diminished and prone to apoptotic deletion. In this study, we investigate whether …

[HTML][HTML] Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection

G Nebbia, D Peppa, A Schurich, P Khanna, HD Singh… - PloS one, 2012 - journals.plos.org
The S-type lectin galectin-9 binds to the negative regulatory molecule Tim-3 on T cells and
induces their apoptotic deletion or functional inactivation. We investigated whether galectin-9/…

Temporal analysis of early immune responses in patients with acute hepatitis B virus infection

C Dunn, D Peppa, P Khanna, G Nebbia, M Jones… - Gastroenterology, 2009 - Elsevier
BACKGROUND & AIMS: Hepatitis B virus (HBV) causes more than 1 million deaths annually
from immune-mediated liver damage. The long incubation period has been difficult to study; …